These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11254546)

  • 41. [Current news about epidemiology of syncytial respiratory virus infection].
    Palumbo E
    Recenti Prog Med; 2008 May; 99(5):237-9. PubMed ID: 18581965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Respiratory syncytial virus bronchiolitis: prevention and treatment.
    Faber TE; Kimpen JL; Bont LJ
    Expert Opin Pharmacother; 2008 Oct; 9(14):2451-8. PubMed ID: 18778183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RSV disease--is there a role for prevention?
    Lenney W
    Respir Med; 2001 Mar; 95(3):170-2. PubMed ID: 11266232
    [No Abstract]   [Full Text] [Related]  

  • 45. Palivizumab.
    Gupta D; Gupta P
    Indian Pediatr; 2001 Nov; 38(11):1265-9. PubMed ID: 11721066
    [No Abstract]   [Full Text] [Related]  

  • 46. Palivizumab and RSV prevention.
    Lenney W
    Arch Dis Child; 2000 Jul; 83(1):87. PubMed ID: 10960342
    [No Abstract]   [Full Text] [Related]  

  • 47. Palivizumab and RSV prevention.
    Carnegie C
    Arch Dis Child; 2000 Jul; 83(1):87. PubMed ID: 10960341
    [No Abstract]   [Full Text] [Related]  

  • 48. Viral infections and childhood asthma.
    Kimpen JL
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 2):S108-12. PubMed ID: 10988163
    [No Abstract]   [Full Text] [Related]  

  • 49. Palivizumab (Synagis) for prevention of RSV infection.
    Med Lett Drugs Ther; 1999 Jan; 41(1043):3-4. PubMed ID: 9924488
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhalation of corticosteroids after hospital care for respiratory syncytial virus infection diminishes development of asthma in infants.
    Hesselmar B; Adolfsson S
    Acta Paediatr; 2001 Mar; 90(3):260-3. PubMed ID: 11332164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RespiGam: an RSV immune globulin.
    Oertel MD
    Pediatr Nurs; 1996; 22(6):525-8. PubMed ID: 9087091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response to respiratory synctial virus.
    Hampp C; Winterstein AG
    South Med J; 2008 Feb; 101(2):212-3; author reply 213-4. PubMed ID: 18364631
    [No Abstract]   [Full Text] [Related]  

  • 54. Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease.
    Taylor G; Porter T; Dillon S; Trill J; Ganguly S; Hart T; Davis C; Wyde P; Tempest P; Harris W
    Biochem Soc Trans; 1995 Nov; 23(4):1063-7. PubMed ID: 8654682
    [No Abstract]   [Full Text] [Related]  

  • 55. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
    Cabalka AK
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylaxis with palivizumab against respiratory syncytial virus infection in infants with congenital heart disease--who should receive it?
    Sunnegårdh J
    Acta Paediatr; 2006 Apr; 95(4):388-90. PubMed ID: 16720482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children.
    Abarca K; Jung E; Fernández P; Zhao L; Harris B; Connor EM; Losonsky GA;
    Pediatr Infect Dis J; 2009 Apr; 28(4):267-72. PubMed ID: 19258920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viruses and atopic sensitization in the first years of life.
    Martinez FD
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 2):S95-9. PubMed ID: 10988160
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoprophylaxis of respiratory syncytial virus disease.
    Sánchez PJ
    Pediatr Infect Dis J; 2000 Aug; 19(8):791-801; discussion 802-4. PubMed ID: 10959760
    [No Abstract]   [Full Text] [Related]  

  • 60. RSVIG and palivizumab: not the same.
    Fisher RG
    Pediatr Infect Dis J; 2000 Mar; 19(3):270. PubMed ID: 10749481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.